afatinib is a protein kinase inhibitor, it is used for the treatment of patients with distinct types of metastatic (EGFR mutation positive) non-small cell lung carcinoma (NSCLC), developed by Boehringer Ingelheim. It is also known as Gilotrif and Giotrif. Reference standards of Afatinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Afatinib-d6 [catalogue_number] => PA STI 004271 [category_ids] => ,98, [chemical_name] => [weight] => 491.98 [form] => C24H19D6ClFN5O3 [cas] => 1313874-96-2 [pslug] => 1313874-96-2-afatinib-d6-pasti004271 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA STI 004271
CAS :
Molecular Formula : C24H19D6ClFN5O3
Molecular Weight : 491.98
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....